Skip to main content
Nureca Limited logo

Nureca Limited — Investor Relations & Filings

Ticker · NURECA ISIN · INE0DSF01015 LEI · 894500NRGNYR07CDBN26 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 302 across all filing types
Latest filing 2026-05-24 Legal Proceedings Report
Country IN India
Listing BSE.NS NURECA

About Nureca Limited

https://www.nureca.com

Nureca Limited specializes in the development and distribution of home healthcare devices and lifestyle products. The company operates through several key brands, most notably Dr Trust, Dr Physio, and Trumom. Its product portfolio includes medical diagnostic tools such as blood pressure monitors, pulse oximeters, nebulizers, and thermometers, as well as wellness equipment like massagers and personal scales. Nureca utilizes a digital-first business model, prioritizing e-commerce channels to provide consumers with accessible medical technology. The company focuses on integrating clinical-grade accuracy with user-centric design to support chronic disease management, fitness tracking, and maternal care. By offering a diverse range of health monitoring solutions, Nureca aims to empower individuals to manage their well-being through proactive and data-driven home-based care.

Recent filings

Filing Released Lang Actions
Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requiremnets )Regulations,2015.
Legal Proceedings Report Classification · 85% confidence The document is an intimation under SEBI Regulation 30 disclosing receipt of a hearing notice from the Directorate of Revenue Intelligence and related legal proceedings. It is not announcing financial results or share issues, but providing a legal update. This aligns with a Legal Proceedings Report (LTR).
2026-05-24 English
General Updates
Regulatory Filings Classification · 90% confidence The document is a regulatory intimation under SEBI Listing Obligations and Disclosure Requirements (Regulation 30) announcing a hearing notice from the Directorate of Revenue Intelligence and a pre-deposit. It contains no financial statements, presentation materials, earnings data, or AGM/EGM voting results. It is a routine compliance/disclosure filing to the stock exchange. It best fits the fallback category for general regulatory announcements (Regulatory Filings).
2026-05-24 English
Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Nureca Limited has informed the Exchange ....
Regulatory Filings Classification · 85% confidence The document is a formal notice under SEBI Listing Regulations informing stock exchanges of an upcoming Board meeting on May 29, 2026 to consider and approve audited financial results. It does not itself contain financial statements or summaries, nor is it an AGM/EGM proxy or voting result. It is a routine regulatory disclosure of a board meeting, which falls under general regulatory filings. Therefore, it is classified as Regulatory Filings (RNS).
2026-05-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, issued by the Registrar and Share Transfer Agent for the quarter ended March 31, 2026. It is a compliance certificate related to shareholding or depository participant regulations, not a financial report or announcement of financial results. The document is short (2069 characters) and is a formal attestation or certification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and certifications that do not fit other specific categories.
2026-04-15 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice about the closure of the trading window for insiders ahead of the announcement of audited financial results for the fiscal year ending March 31, 2026. It is a compliance communication related to insider trading regulations and does not contain any financial data or results itself. The document is short (1643 characters) and serves as an announcement rather than a report. It does not fit into categories like Annual Report, Earnings Release, or Interim Report. It is also not a certification or legal proceeding. The best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2026-03-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.